The US Centers for Disease Control and Prevention has told public health officials around the United States to prepare to distribute a potential coronavirus vaccine as soon as late October. It also provided planning scenarios to help states prepare.
The documents were posted by The New York Times and the CDC confirmed to CNN it has sent them to city and state public health officials.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19. The Assure COVID-19 IgG/IgM Rapid Test Device was first authorized for emergency use by certain labs in July 2020 to help identify individuals with antibodies to SARS-CoV-2, indicating recent or prior COVID-19 infection. Today, that EUA is being reissued to authorize the test for POC use using fingerstick blood samples.
MOSCOW (Reuters) - Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow as an answer to its critics.
The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.
The first peer-reviewed results of Phase 1 and Phase 2 clinical trials of Russia’s coronavirus vaccine, which is named Sputnik-V, have been published in the medical journal The Lancet on Friday.
Results from the two 42-day trials – which each included 38 healthy adults – “have a good safety profile with no serious adverse events” among participants, The Lancet said in a press release, noting that the vaccine-induced antibody responses in all participants.
When news broke last week that a man living in Hong Kong had been infected with the coronavirus again, months after recovering from a previous bout of COVID-19, immunologist Akiko Iwasaki had an unusual reaction. “I was really kind of happy,” she says. “It’s a nice textbook example of how the immune response should work.”
The U.S. will not join a global initiative to secure and distribute a coronavirus vaccine led by the World Health Organization and others, according to a White House official.
Earlier this summer, the Summit supercomputer at Oak Ridge National Lab in Tennessee set about crunching data on more than 40,00
Do masks really work? Ask the dozens of Starbucks customers who tested positive for COVID-19 in Seoul this month after a woman with coronavirus sat under one of the cafe’s air-conditioners.
According to a local news report, at least 56 coronavirus cases have been linked to that one customer. The kicker: The four masked workers avoided infection.
ollowing the news this week of what appears to have been the first confirmed case of a Covid-19 reinfection, other researchers have been coming forward with their own reports. One in Belgium, another in the Netherlands. And now, one in Nevada.
A Nevada resident is thought to be the first person in the United States to be infected twice by the coronavirus, according to findings released this week.
The 25-year-old man, of Reno, experienced a sore throat, cough, headache, nausea and diarrhea — and first tested positive for the COVID-19 on April 18, according to a study published to the website SSRN Thursday, which has yet to be peer-reviewed.
